Thank you to everyone who stopped by to meet the i2e team at the EP3M Summit 2026 in Boston. It was a privilege to sponsor an event that brought together pharma and biotech leaders to shape the future of project, program, and portfolio management.
Two days. Countless conversations. One clear theme.
As R&D portfolios grow more complex, organizations need greater visibility, alignment, and data-driven insight to decide with confidence.
Missed us in Boston? Let’s pick up where we left off.

At i2e Consulting, we help pharmaceutical organizations streamline R&D planning, resource management, processes, and systems across the project and portfolio lifecycle. By connecting data, workflows, and decision making, we help teams improve visibility, plan resources more effectively, and focus on strategic priorities. Rooted in life sciences domain expertise, we partner with organizations to improve portfolio planning through data-driven insights, intelligent automation, and scalable solutions that support better decisions and more effective execution.
Whether we met at the summit or missed each other, share your details and our team will follow up.
By submitting this form, you agree to our Terms of Use and Privacy Policy. Information provided by you may be collected and automatically stored in our database and may be used for sending you additional information about i2e Consulting and our services.
Organized by Cambridge Healthtech Institute (CHI), it is a two-day event where pharma and biotech leaders come together to align strategy with execution, apply data and AI to sharpen portfolio decisions, and build governance frameworks resilient enough to handle shifting markets and regulatory change.